Fatih Noyan

3.1k total citations
35 papers, 977 citations indexed

About

Fatih Noyan is a scholar working on Immunology, Genetics and Hepatology. According to data from OpenAlex, Fatih Noyan has authored 35 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Genetics and 10 papers in Hepatology. Recurrent topics in Fatih Noyan's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers) and Liver Diseases and Immunity (9 papers). Fatih Noyan is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (12 papers) and Liver Diseases and Immunity (9 papers). Fatih Noyan collaborates with scholars based in Germany, Canada and United States. Fatih Noyan's co-authors include Elmar Jaeckel, Matthias Hardtke‐Wolenski, Michael P. Manns, Jérôme Schlué, Richard Taubert, Christine S. Falk, A. Knoefel, Katharina Zimmermann, Melanie Galla and Robert Geffers and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Hepatology.

In The Last Decade

Fatih Noyan

35 papers receiving 969 citations

Peers

Fatih Noyan
Dominic Borie United States
Angela Lares United States
Dean Kavanagh United Kingdom
Markus Müschen United States
Jennifer Baker United Kingdom
Dominic Borie United States
Fatih Noyan
Citations per year, relative to Fatih Noyan Fatih Noyan (= 1×) peers Dominic Borie

Countries citing papers authored by Fatih Noyan

Since Specialization
Citations

This map shows the geographic impact of Fatih Noyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatih Noyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatih Noyan more than expected).

Fields of papers citing papers by Fatih Noyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatih Noyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatih Noyan. The network helps show where Fatih Noyan may publish in the future.

Co-authorship network of co-authors of Fatih Noyan

This figure shows the co-authorship network connecting the top 25 collaborators of Fatih Noyan. A scholar is included among the top collaborators of Fatih Noyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatih Noyan. Fatih Noyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dywicki, Janine, Laura Elisa Buitrago‐Molina, Anna Baumann, et al.. (2025). From model to man: Understanding Tregs' dual role in MASLD. JHEP Reports. 7(12). 101619–101619. 1 indexed citations
2.
Hardtke‐Wolenski, Matthias, Danny Jonigk, Melanie Galla, et al.. (2024). Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction. Cells. 13(14). 1216–1216. 2 indexed citations
3.
Ravens, Sarina, Immo Prinz, Laura Elisa Buitrago‐Molina, et al.. (2022). PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer. Liver Cancer. 12(2). 129–144. 9 indexed citations
4.
Simon, Daniel, Tobias Riët, Christine S. Falk, et al.. (2022). Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors. Frontiers in Immunology. 13. 1005582–1005582. 17 indexed citations
5.
Buitrago‐Molina, Laura Elisa, Janine Dywicki, Fatih Noyan, et al.. (2021). Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration. Cells. 10(6). 1471–1471. 8 indexed citations
6.
Jyotsana, Nidhi, Amit Sharma, Anuhar Chaturvedi, et al.. (2019). Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo. Annals of Hematology. 98(8). 1905–1918. 76 indexed citations
7.
Vondran, Florian W. R., Roland Schmitt, Michael P. Manns, et al.. (2019). Transient increase of activated regulatory T cells early after kidney transplantation. Scientific Reports. 9(1). 1021–1021. 20 indexed citations
8.
Taubert, Richard, Matthias Hardtke‐Wolenski, Fatih Noyan, et al.. (2017). Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLoS ONE. 12(6). e0179074–e0179074. 28 indexed citations
9.
Hardtke‐Wolenski, Matthias, Janine Dywicki, Katja Fischer, et al.. (2016). The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development. Journal of Autoimmunity. 78. 39–45. 21 indexed citations
10.
Noyan, Fatih, Katharina Zimmermann, Matthias Hardtke‐Wolenski, et al.. (2016). Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. American Journal of Transplantation. 17(4). 917–930. 225 indexed citations
11.
Taubert, Richard, Matthias Hardtke‐Wolenski, Fatih Noyan, et al.. (2014). Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. Journal of Hepatology. 61(5). 1106–1114. 113 indexed citations
12.
Noyan, Fatih, Katharina Zimmermann, Matthias Hardtke‐Wolenski, et al.. (2014). Isolation of human antigen‐specific regulatory T cells with high suppressive function. European Journal of Immunology. 44(9). 2592–2602. 36 indexed citations
13.
Hardtke‐Wolenski, Matthias, Katja Fischer, Fatih Noyan, et al.. (2013). Genetic Predisposition and Environmental Danger Signals Initiate Chronic Autoimmune Hepatitis Driven by CD4+ T Cells. Hepatology. 58(2). 718–728. 65 indexed citations
14.
Hardtke‐Wolenski, Matthias, Christel Schmetz, Fatih Noyan, et al.. (2013). Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth. PLoS ONE. 8(10). e78558–e78558. 4 indexed citations
15.
Noyan, Fatih, Matthias Hardtke‐Wolenski, A. Knoefel, et al.. (2013). Donor-specific Regulatory T Cells Generated on Donor B Cells Are Superior to CD4+CD25high Cells in Controlling Alloimmune Responses in Humanized Mice. Transplantation Proceedings. 45(5). 1832–1837. 19 indexed citations
16.
Noyan, Fatih, Inés Avedillo Díez, Martin Hapke, Christoph Klein, & Ricardo A. Dewey. (2012). Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy. Cancer Gene Therapy. 19(5). 352–357. 14 indexed citations
17.
Taubert, Richard, Sven Pischke, Jérôme Schlué, et al.. (2012). Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts. American Journal of Transplantation. 12(12). 3425–3436. 34 indexed citations
18.
Rathinam, Chozhavendan, Maria Schubert, Fatih Noyan, et al.. (2009). MAPKAP kinase MK2 maintains self‐renewal capacity of haematopoietic stem cells. The EMBO Journal. 28(10). 1392–1406. 25 indexed citations
19.
Adıgüzel, Cafer, et al.. (2007). A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate.. PubMed. 24(1). 28–31. 1 indexed citations
20.
Dewey, Ricardo A., Inés Avedillo Díez, Matthias Ballmaier, et al.. (2006). Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. Experimental Hematology. 34(9). 1161–1169. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026